Slide 1Management of Primary Neuroendocrine Tumors Surgical Management of Primary Neuroendocrine Tumors Carl R. Schmidt, MD, FACS Slide 2 Management of Primary Neuroendocrine…

Slide 1©2013 MFMER | slide-1 Advancing Health Literacy of Transplant Patients and Caregivers Julia G Behrenbeck, MS, MPH, RN, Rachel F Carroll MAE, BAS, William Sanchez,…

Slide 1 8th Banff Conference on Allograft PathologyEdmonton, 15-21 July 2005 Proteinuria with sirolimus therapy. Christophe Legendre Hôpital Necker, Université Paris V…

Slide 1 Slide 2 Slide 3 Slide 4 Strongyloides stercoralis in transplant patients Alisa Alker Slide 5 Life cycle Slide 6 Geographic distribution ❖ Over 50 million people…

Phase III study of first-line XELOX plus bevacizumab (BEV) for 6 cycles followed by XELOX plus BEV or single agent (s/a) BEV as maintenance therapy in patients (pts) with…

Gray Zone Lymphoma (GZL) with Features Intermediate between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective Multicenter…